Date:5/11/2009

$1,015 to $1,025 $1,015 to $1,025 Gross margin as a % of total revenue 79% to 80% 79% to 80% SG&A Expenses: -------------- A&P $44 to $47 $41 to $44 Selling & Distribution $91 to $94 $84 to $87 G&A $64 to $67 $78 to $81 Total SG&A Expenses (2) $199 to $208 $203 to $212 Total R&D (3) $77 to $80 $77 to $80 GAAP Net Income (4) $174 to $186 $174 to $186 CNI (5) $390 to $402 $390 to $402 CNI per share (5) (6) $1.55 to $1.60 $1.55 to $1.60 -------------- (1) Our 2009 guidance does not account for the impact of any future new licensing agreements. (2) Total SG&A expenses do not include any amount that may be payable in connection with the potential settlement of our outstanding legal actions. (3) Total 2009 R&D expense consists of internal R&D anticipated to be in the range of $61.5 to $64.5 million. Included in total 2009 R&D expense are $11.5 million of milestone payments expensed during the quarter ended March 31, 2009, as well as $4.0 million of anticipated future milestone payments. (4) The effective GAAP tax rate for 2009 is expected to be in the mid-to- high teens. (5) A reconciliation of 2009 GAAP net income to CNI adds back the expected after tax impact of amortization of intangibles ($209M) and the expected after tax impact of the amortization and write-offs of deferred loan costs ($7M). (6) CNI per share is based on 251.4 million fully diluted Class A shares.

'/>"/>

SOURCE Warner Chilcott Limited Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine news :

1. Warner Chilcott Proposes Redomestication From Bermuda to Ireland
2. Warner Chilcott to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
3. Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
4. HBO, Warner Bros. Employee Initiatives and the Alzheimers Association, California Southland Chapter Present a Free, Public, Advance Screening of THE ALZHEIMERS PROJECT: Caregivers
5. Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2009 Financial Results
6. Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
7. Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
8. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
9. Virginia Faith Leaders Call on Senators Webb & Warner to Support Legislation to Protect Kids from Tobacco
10. Virginia Faith Leaders Call on Sens. Webb & Warner to Support Legislation to Protect Kids From Tobacco
11. Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008